Buprenorphine Medication Versus Voucher Contingencies in Promoting Abstinence From Opioids and Cocaine

Experimental and Clinical Psychopharmacology

Volumn 17, Issue 4, 2009, Pages 226-236

  Chopra, Mohit P ^a   Landes, Reid D ^b   Gatchalian, Kirstin M ^c   Jackson, Lisa C ^c   Buchhalter, August R ^d   Stitzer, Maxine L ^e   Marsch, Lisa A ^f   Bickel, Warren K ^c  

^a Boston Healthcare System   (United States)

^b Department of Biostatistics ^*

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d Pinney Associates   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

buprenorphine; cocaine; community reinforcement approach; contingency management; opiate or opioid dependence

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COCAINE DEPENDENCE; COMPUTER; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EMPLOYMENT STATUS; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PATIENT COUNSELING; PROSPECTIVE PAYMENT; PSYCHOTHERAPIST; REINFORCEMENT; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT RESPONSE; URINALYSIS; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; BUPRENORPHINE; COCAINE-RELATED DISORDERS; DIRECTIVE COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; RECURRENCE; REWARD;

EID: 69049098954     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0016597     Document Type: Article

References (37)

1. Aickin M. A program for balancing the allocation of subjects to treatment in a clinical trial. Computers and Biomedical Research 15 (1982) 519-524
2. Amass L., Bickel W.K., Crean J.P., Blake J., and Higgins S.T. Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans. Psychopharmacology 136 (1998) 217-225
3. Amass L., Bickel W.K., Higgins S.T., and Badger G.J. Alternate-day dosing during buprenorphine treatment of opioid dependence. Life Sciences 54 (1994) 1215-1228
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), Author, Washington, DC
5. Bickel W.K., Amass L., Crean J.P., and Badger G.J. Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients. Psychopharmacology 146 (1999) 111-118
6. Bickel W.K., Amass L., Higgins S.T., Badger G.J., and Esch R. Effects of adding behavioral treatment to opioid detoxification with buprenorphine. Journal of Consulting and Clinical Psychology 65 (1997) 803-810
7. Bickel W.K., Marsch L.A., Buchhalter A.R., and Badger G.J. Computerized behavior therapy for opioid-dependent outpatients: A randomized controlled trial. Experimental and Clinical Psychopharmacology 16 (2008) 132-143
8. Brooner R.K., Kidorf M.S., King V.L., Stoller K.B., Neufeld K.J., and Kolodner K. Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence. Drug and Alcohol Dependence 88 Suppl. 2 (2007) S14-S23
9. Budney A.J., and Higgins S.T. A community reinforcement plus vouchers approach: Treating cocaine addiction (1998), U.S. Department of Health and Human Services, National Institute on Drug Abuse, Rockville, MD
10. Carroll K.M., Ball S.A., Martino S., Nich C., Babuscio T.A., Nuro K.F., et al. Computer-assisted delivery of cognitive-behavioral therapy for addiction: A randomized trial of CBT4CBT. American Journal of Psychiatry 165 (2008) 881-888
11. Chutuape M.A., Silverman K., and Stitzer M.L. Use of methadone take-home contingencies with persistent opiate and cocaine abusers. Journal of Substance Abuse Treatment 16 (1999) 23-30
12. Downey K.K., Helmus T.C., and Schuster C.R. Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance. Experimental and Clinical Psychopharmacology 8 (2000) 176-184
13. Dutra L., Stathopoulou G., Basden S.L., Leyro T.M., Powers M.B., and Otto M.W. A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry 165 (2008) 179-187
14. Good P. Permutation, parametric and bootstrap tests of hypotheses. 3rd ed. (2005), Springer Science+Business Media, Inc, New York
15. Gross A., Marsch L.A., Badger G.J., and Bickel W.K. A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine. Experimental and Clinical Psychopharmacology 14 (2006) 148-156
16. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E., Donham R., and Badger G.J. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Archives of General Psychiatry 51 (1994) 568-576
17. Higgins S.T., Delaney D., Budney A.J., Bickel W.K., Hughes J.R., Feorg F., et al. A behavioral approach to achieving initial cocaine abstinence. American Journal of Psychiatry 148 (1991) 1218-1224
18. Hunt D., Spunt B., Lipton D., Goldsmith D., and Strug D. The costly bonus: Cocaine related crime among methadone treatment clients. Advances in Alcohol and Substance Abuse 6 (1986) 107-122
19. Iguchi M., Stitzer M.L., Bigelow G.E., and Liebson I.A. Contingent methadone delivery: Effects on illicit-opiate use. Drug and Alcohol Dependence 17 (1988) 311-322
20. Kirby K.C., Benishek L.A., Dugosh K.L., and Kerwin M.E. Substance abuse treatment providers' beliefs and objections regarding contingency management: Implications for dissemination. Drug and Alcohol Dependence 85 (2006) 19-27
21. Kolar A.F., Brown B.S., Weddington W.W., and Ball J.C. A treatment crisis: Cocaine use by clients in methadone maintenance programs. Journal of Substance Abuse Treatment 7 (1990) 101-107
22. Kosten T.R., Rounsaville B.J., and Kleber H.D. Antecedents and consequences of cocaine abuse among opioid addicts: A 2.5-year follow-up. Journal of Nervous and Mental Disease 176 (1988) 176-181
23. Leal J., and Galanter M. The use of contingency contracting to improve outcome in methadone maintenance. Substance Abuse 16 (1995) 155-165
24. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., and Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 101 (2006) 192-203
25. Magura S., Nwakeze P.C., and Demsky S.Y. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 93 (1998) 51-60
26. McGovern M.P., Fox T.S., Xie H., and Drake R.E. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system. Journal of Substance Abuse Treatment 26 (2004) 305-312
27. McLellan A.T., Luborsky L., Cacciola J., Griffith J., Evans F., Barr H., et al. New data from the Addiction Severity Index. Reliability and validity in three centers. Journal of Nervous and Mental Diseases 173 (1985) 412-423
28. Nolimal D., and Crowley T.J. Difficulties in a clinical application of methadone-dose contingency contracting. Journal of Substance Abuse Treatment 7 (1990) 219-224
29. Prendergast M., Podus D., Finney J., Greenwell L., and Roll J. Contingency management for the treatment of substance use disorders: A meta-analysis. Addiction 101 (2006) 1546-1560
30. Reece A.S. Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program. Substance Abuse and Treatment Prevention Policy 2 (2007) 35-50
31. Roozen H.G., Boulogne J.J., van Tulder M.W., van den Brink W., De Jong C.A., and Kerkhof A.J. A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug and Alcohol Dependence 74 (2004) 1-13
32. Silverman K., Robles E., Mudric T., Bigelow G.E., and Stitzer M.L. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs. Journal of Consulting and Clinical Psychology 72 (2004) 839-854
33. Stitzer M., and Petry N. Contingency management for treatment of substance abuse. Annual Review of Clinical Psychology 2 (2006) 411-434
34. Stitzer M.L., Bickel W.K., Bigelow G.E., and Liebson I.A. Effects of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients. Drug and Alcohol Dependence 18 (1986) 341-348
35. Stitzer M.L., Peirce J., Petry N.M., Kirby K., Roll J., Krasnansky J., et al. Abstinence-based incentives in methadone maintenance: Interaction with intake stimulant test results. Experimental and Clinical Psychopharmacology 15 (2007) 344-350
36. Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: National Findings (2008), Office of Applied Studies, Department of Health and Human Services, Rockville, MD. http://oas.samhsa.gov/nsduh/2k7nsduh/2k7Results.pdf Also online at: http://oas.samhsa.gov/nsduh/2k7nsduh/2k7Results.pdf
37. Wasserman D.A., Weinstein M.G., Havassy B.E., and Hall S.M. Factors associated with lapses to heroin use during methadone maintenance. Drug and Alcohol Dependence 52 (1998) 183-219